Mental Health DailyResearch. Evidence. Perspective.Published research on psychedelics.
A 2026 preclinical study found that 25C-NBF, a selective 5-HT2A psychedelic phenethylamine, increased plasticity-related markers and produced rapid antidepressant-like effects in male rodent…
Read articleA 2026 mechanistic study involving 28 healthy adults found that a single 25 mg psilocybin session changed acute brain entropy, psychological insight, well-being, cognitive flexibility, and s…
Read articleA 2026 study involving 32 adult mangrove rivulus fish pairs found that 3,000 µg/L waterborne psilocybin reduced movement and aggressive swimming bursts, but the result belongs in animal beha…
Read articleA 2026 eLife computational study modeled classical psychedelics by increasing a network state variable from alpha = 0 to alpha = 1, shifting perception from bottom-up sensory inference towar…
Read articleMedia coverage of psychedelics outpaces the trial evidence. MDMA-PTSD signals are large; psilocybin-depression effects shrink against active comparators.
Read articleThe intersection of mental health treatment and pharmacology is witnessing a remarkable shift with the growing interest in ketamine and classic psychedelics like psilocybin for their rapid a…
Read articleIn the quest for innovative treatments for psychiatric disorders, the study of psychedelics has taken a significant leap forward. Among these, Dimethyltryptamine (DMT), known for its rapid o…
Read article
